China Hospital Priorities — Strategic Themes and Implications for Medtechs

Stephen Sunderland

hospital priorities

collaboration with APACMed

background of survey

implications with medtechs

medical equipment growth

decisions based on purchasing

clinical outcomes for medtech

telemedicine growth

Hospitals remain highly expansionary

hospitals are innovation-related

hospitals with more emphasis

basic digitalization

EHR adoption

VBP medtech

expected trend of VBP

improving labor efficiency

large hospitals state willingness to work

Hospitals appear enthusiastic

support clinical decision-making

education programs and equipment management services

disclaimer

about the authors

Related Insights

Life Sciences & Pharma • Article

ASCO 2021 Social Listening: Major Data Readouts and Themes

July 27, 2021

L.E.K. Consulting used social listening to gauge the sentiment of virtual attendees at the ASCO 2021 meeting.

Life Sciences & Pharma • Executive Insights

Trends in Pharma Asset Licensing and Deal Terms: A Survey of Key Decision-Makers

March 19, 2021

In this Executive Insights, we describe some key drivers of asset value, as well as areas of alignment on and divergence from deal expectations between…

Life Sciences & Pharma • Executive Insights

Preparedness, Policy And Patients – Learning From The Pandemic

May 19, 2021

We must ask what we have learnt from our recent experiences that can be deployed to help accelerate approaches to fighting other, similarly devastating,…

Life Sciences & Pharma • Executive Insights

After Faltering Start, Japan’s Biosimilars Market Appears on Cusp of Rapid Growth

November 16, 2020

Japan has continued to ensure reasonably favorable pricing and access for innovative drugs, biosimilars have received surprisingly little attention from…

Life Sciences & Pharma • Special Report

Making the AI Leap: Boosting Singapore’s Competitiveness in Biotech

December 17, 2020

Following years of investment through artificial intelligence (AI)-centric venture funds and government grants, Singapore has moved beyond applying AI to…

Life Sciences & Pharma • Executive Insights

European Drug Pricing and Market Access in a COVID-19 World

October 14, 2020

On 3 June 2020, Médecins Sans Frontières (MSF) issued an appeal urging world leaders to ensure that pharmaceutical companies sell any COVID-19 vaccines at…